• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏结石管理的更新与实用指南。

An update and practical guide to renal stone management.

机构信息

Centre for Nephrology, UCL Medical School, Royal Free Campus, London, UK.

出版信息

Nephron Clin Pract. 2010;116(3):c159-71. doi: 10.1159/000317196. Epub 2010 Jul 2.

DOI:10.1159/000317196
PMID:20606476
Abstract

Renal stone disease covers kidney and lower urinary tract stones caused by a variety of conditions, including metabolic and inherited disorders, and anatomical defects with or without chronic urinary infection. Most cases are idiopathic, in which there is undoubtedly a genetic predisposition, but where environmental and lifestyle factors play an important role. Indeed, it is becoming apparent that renal stone disease is often part of a larger 'metabolic picture' commonly associated with type 2 diabetes, obesity, dyslipidaemia, and hypertension. Renal stone disease is a growing problem in the UK (and other developed and developing populations) with a cross-sectional prevalence of ∼1.2%. This means that there are currently ∼720,000 individuals with a history of kidney stones in the UK. Almost 40% of first-time stone formers will form a second stone within 3 years of the first episode if no prophylactic measures are instituted to prevent stone recurrence, since removal or disintegration of the first stone does not treat the underlying cause of stones in the majority of patients. The age of onset is getting younger and the sex ratio (until recently more men than women) is becoming almost even. Metabolic screening remains an important part of investigating renal stone disease, but to the disappointment and frustration of many doctors, medical treatment is still essentially pragmatic, except perhaps in cystinuria, and to a limited extent in primary hyperoxaluria (if pyridoxine-sensitive); although newer treatments may be emerging. This review summarizes current thinking and provides a practical basis for the management of renal stone disease.

摘要

肾结石病涵盖了由多种情况引起的肾脏和下尿路结石,包括代谢和遗传紊乱,以及伴有或不伴有慢性尿路感染的解剖缺陷。大多数病例是特发性的,其中无疑存在遗传易感性,但环境和生活方式因素也起着重要作用。事实上,越来越明显的是,肾结石病通常是与 2 型糖尿病、肥胖症、血脂异常和高血压等更为广泛的“代谢图景”相关的一部分。肾结石病在英国(以及其他发达国家和发展中国家)是一个日益严重的问题,横断面患病率约为 1.2%。这意味着目前英国有大约 72 万人有肾结石病史。如果不采取预防措施来防止结石复发,首次结石形成者中有近 40%会在首次发作后 3 年内形成第二个结石,因为大多数患者的结石复发的根本原因并没有得到治疗,即使去除或分解了第一个结石。发病年龄越来越年轻,性别比例(直到最近男性多于女性)几乎持平。代谢筛查仍然是肾结石病研究的重要组成部分,但令许多医生失望和沮丧的是,除了胱氨酸尿症(在一定程度上还包括原发性高草酸尿症(如果对吡哆醇敏感))之外,医学治疗基本上仍然是实用主义的;尽管可能会出现新的治疗方法。这篇综述总结了当前的思维,并为肾结石病的管理提供了实用的基础。

相似文献

1
An update and practical guide to renal stone management.肾脏结石管理的更新与实用指南。
Nephron Clin Pract. 2010;116(3):c159-71. doi: 10.1159/000317196. Epub 2010 Jul 2.
2
Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.社区首次出现症状性肾结石患者的结石成分
Mayo Clin Proc. 2015 Oct;90(10):1356-65. doi: 10.1016/j.mayocp.2015.07.016. Epub 2015 Sep 6.
3
Kidney stone disease.肾结石病
J Clin Invest. 2005 Oct;115(10):2598-608. doi: 10.1172/JCI26662.
4
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.肾结石形成的尿液危险因素的饮食治疗。CLU工作组综述
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
5
[Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].[非钙性肾结石的病理生理学、诊断及保守治疗]
Ther Umsch. 2003 Feb;60(2):89-97. doi: 10.1024/0040-5930.60.2.89.
6
Metabolic stone composition in Egyptian children.埃及儿童的代谢性结石成分
J Pediatr Urol. 2009 Apr;5(2):132-5. doi: 10.1016/j.jpurol.2008.11.002. Epub 2008 Dec 6.
7
Predisposing factors and prevention of renal calculi.
Compr Ther. 1986 Dec;12(12):43-9.
8
[Clinical and metabolic features of renal calculi in adults in regard to age of onset].[成人肾结石的临床和代谢特征与发病年龄的关系]
Minerva Urol Nefrol. 1999 Jun;51(2):71-4.
9
[Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].[钙肾结石的病理生理学、诊断及保守治疗]
Ther Umsch. 2003 Feb;60(2):79-87. doi: 10.1024/0040-5930.60.2.79.
10
Nephrolithiasis: current concepts in medical management.
Urol Radiol. 1984;6(2):74-9. doi: 10.1007/BF02923706.

引用本文的文献

1
Genetically predicted blood metabolites mediate the association between immune cell characteristics and urolithiasis: A Mendelian randomization study and mediation analysis.基因预测的血液代谢物介导免疫细胞特征与尿石症之间的关联:一项孟德尔随机化研究和中介分析。
Genes Dis. 2025 Jan 28;12(5):101547. doi: 10.1016/j.gendis.2025.101547. eCollection 2025 Sep.
2
Metabolic evaluation and disease characteristics of urolithiasis in children from 2020 to 2024: a retrospective single-center study at the national children's medical center.2020年至2024年儿童尿路结石的代谢评估与疾病特征:国家儿童医学中心的一项回顾性单中心研究
BMC Pediatr. 2025 Jul 2;25(1):505. doi: 10.1186/s12887-025-05773-8.
3
SMART Stone Multidisciplinary Team (MDT) and patient care: recommendations for the adult high-risk kidney stone patient pathway.
SMART结石多学科团队(MDT)与患者护理:成人高危肾结石患者诊疗路径建议
World J Urol. 2025 Apr 22;43(1):240. doi: 10.1007/s00345-025-05602-8.
4
A cross-sectional study of the association between plant-based diet indices and kidney stones among Iranian adults.一项关于伊朗成年人植物性饮食指数与肾结石之间关联的横断面研究。
Sci Rep. 2025 Apr 18;15(1):13495. doi: 10.1038/s41598-025-98370-9.
5
Association of neutrophil to lymphocyte ratio with all-cause and cardiovascular mortality among individuals with kidney stone disease: result from NHANES, 2007-2018.肾结石病患者中性粒细胞与淋巴细胞比值与全因死亡率和心血管死亡率的关联:2007 - 2018年美国国家健康与营养检查调查结果
Front Endocrinol (Lausanne). 2025 Mar 14;16:1537403. doi: 10.3389/fendo.2025.1537403. eCollection 2025.
6
Metabolic Alkalemia in Hypercalciuria Stone Formers: Does It Matter?高钙尿症结石形成者中的代谢性碱血症:这有关系吗?
Kidney Blood Press Res. 2024;49(1):987-1002. doi: 10.1159/000540953. Epub 2024 Oct 24.
7
Causal Effects of Inflammatory Bowel Diseases on the Risk of Kidney Stone Disease.炎症性肠病对肾结石病风险的因果效应
Cureus. 2024 Jun 26;16(6):e63230. doi: 10.7759/cureus.63230. eCollection 2024 Jun.
8
Efficacy of an Oral Solution Containing Five Herbal Extracts in the Treatment of Urolithiasis: A Randomized, Single-blind, Placebo-controlled Clinical Trial.一种含五种草药提取物的口服溶液治疗尿路结石的疗效:一项随机、单盲、安慰剂对照临床试验
J Res Pharm Pract. 2024 Apr 30;12(3):96-103. doi: 10.4103/jrpp.jrpp_11_24. eCollection 2023 Jul-Sep.
9
The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and kidney stones: a cross-sectional study.非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)与肾结石的关系:一项横断面研究。
Lipids Health Dis. 2024 Apr 13;23(1):102. doi: 10.1186/s12944-024-02089-x.
10
Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria.血清硬化蛋白与复发性肾结石形成相关,独立于高钙尿症。
Clin Kidney J. 2023 Nov 1;17(1):sfad256. doi: 10.1093/ckj/sfad256. eCollection 2024 Jan.